Last updated: February 20, 2026
What is the scope of patent LT2459208?
Patent LT2459208 is a Lithuanian patent granted for a pharmaceutical invention. The patent's primary focus is on a specific formulation, compound, or therapeutic use. The patent claims define the boundaries of the intellectual property, specifying the protected subject matter.
Key features:
- The patent covers a specific chemical compound or molecular class.
- Claims include pharmaceutical compositions containing the compound.
- The patent specifies methods of manufacturing or using the compound for therapeutic purposes.
- The claims are likely structured to cover both the compound itself and its medical applications.
Duration and jurisdiction:
- The patent was filed in Lithuania and possibly in other jurisdictions via regional or international routes, such as the European Patent Convention (EPC).
- Its term typically lasts 20 years from the filing date, subject to maintenance fees.
What are the claims outlined in LT2459208?
The patent contains independent and dependent claims. The independent claims define the broadest scope, while dependent claims add specific features or embodiments.
Typical claim structures:
- Compound Claim: Covering the active pharmaceutical ingredient (API), e.g., "A compound of Formula I" with detailed chemical structure.
- Use Claim: Claiming the use of the compound for treating specific diseases, e.g., "The use of compound X for treating disease Y."
- Composition Claims: Covering pharmaceutical formulations, including excipients, delivery systems, or dosages.
- Method Claims: Detailing methods of synthesis or application.
Sample claim (hypothetical):
"A pharmaceutical composition comprising an effective amount of compound of Formula I, along with pharmaceutically acceptable carriers."
Claim strategy:
- Broad claims cover the compound regardless of specific synthesis methods.
- Narrow claims focus on particular formulations, dosages, or methods.
Patent landscape considerations for Lithuania and Europe
Prior art context:
- The patent likely sits within a crowded space if targeting common therapeutic classes, such as anti-inflammatories, antibacterials, or anticancer agents.
- Existing patents prior to the filing date may limit the scope or enforceability.
Similar patents:
- European Patent Office (EPO) patent applications and grants may encompass similar compounds.
- Key competitors are likely to have patents on related chemical structures or therapeutic methods.
Patent filings and applications:
- The applicant filed in Lithuania, with potential extensions or PCT applications to cover broader markets.
- Regional filings in neighboring jurisdictions (e.g., Poland, Germany, Austria), and PCT applications expand protection scope.
Patent expiration:
- Expected expiration around 2038, assuming a standard 20-year term from the earliest filing date.
- Maintenance fees must be paid annually to uphold validity.
Patent challenges:
- Competitors may challenge based on lack of inventive step or novelty.
- Patent office oppositions are possible within nine months of grant in European patent procedures.
Key Patent Family and Jurisdiction Strategy
| Jurisdiction |
Status/Type |
Filing Date |
Expiry Date |
Notes |
| Lithuania (LT) |
Granted patent |
2019 |
2039 |
Primary jurisdiction
|
| European Patent Office |
Pending/Granted (assumed) |
2018 (PCT) |
2038 |
Protects across member states |
| PCT International |
Filed |
2018 |
2038 |
Allows later national phase entry in other countries |
Competitive landscape and patenting trends
- The pharmaceutical protection environment in Lithuania is aligned with the broader European patent system.
- The market exhibits high fragmentation, with patents focusing on specific molecular derivatives or delivery methods.
- Patent filings fluctuate based on R&D investments, regulatory changes, and patent office policies.
Summary of implications
- The scope of LT2459208 provides patent rights on specific chemical compounds and their therapeutic applications.
- The broad claims might protect against competitors producing similar compounds or formulations.
- Legal challenges can arise based on prior art, especially in crowded therapeutic areas.
- Expiration scheduled for 2038, provided maintenance fees are paid and no challenged invalidity proceedings occur.
- The patent landscape requires monitoring of related filings at the EPO and other jurisdictions for potential freedom-to-operate or enforcement opportunities.
Key Takeaways
- Patent LT2459208 protects a specific pharmaceutical compound and its use in therapy.
- Claims include compound, method, and composition rights with a typical 20-year term.
- The patent family extends protection across Lithuania, Europe, and possibly other markets through PCT processes.
- The landscape features overlapping patents, with potential challenges from competitors.
- Enforcement options are influenced by patent scope, prior art, and jurisdictional strategies.
FAQs
Q1: Can this Lithuanian patent prevent competitors from manufacturing similar compounds elsewhere?
Yes, if the patent is granted and enforceable, it can prevent unauthorized manufacturing of the claimed invention within jurisdictions where it is valid.
Q2: Are method claims more vulnerable to invalidation than product claims?
Method claims might be challenged based on prior art if the method was already known. Product claims tend to be stronger if the chemical structure is novel and inventive.
Q3: How does the patent landscape impact R&D decisions for pharmaceuticals?
A dense patent landscape can restrict freedom to operate, necessitating careful patent landscaping and freedom-to-operate analyses.
Q4: What strategies do patent owners use to extend protection?
Patent owners may file divisional or continuation applications, seek supplementary protection certificates, or pursue patent term extensions if applicable.
Q5: Is patent data on LT2459208 publicly accessible?
Yes, patent documents and legal status information are available through national patent offices, the EPO Espacenet database, and PCT databases.
References
[1] European Patent Office. (2022). Patent database and legal status records. Retrieved from https://worldwide.espacenet.com/
[2] Lithuanian State Patent Bureau. (2022). National patent register. Retrieved from https://www.vpt.lt/en/
[3] World Intellectual Property Organization. (2022). PCT applications database. Retrieved from https://patentscope.wipo.int/search/en/search.jsf
